| Pharmaceutical active ingredients: |
| Ondansetron Hydrochloride |
| Available forms, composition and doses of Emetron: |
| Injectable; Injection; Ondansetron Hydrochloride 2 mg / mlTablets, Film-Coated; Oral; Ondansetron Hydrochloride 4 mgTablets, Film-Coated; Oral; Ondansetron Hydrochloride 8 mg |
| Emetron medical category: |
| Human:5-HT3 Receptor AntagonistsAntiemeticsSupportive care therapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A04AA01 - Ondansetron |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Gedeon Richter |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Dantenk | Ondansetron Hydrochloride | Biotenk Laboratorio Farmaceutico |
| Datron | Ondansetron Hydrochloride | GlaxoSmithKline |
| Dismolan | Ondansetron Hydrochloride | P. L. Rivero Laboratorios |
| Doran-O Injections | Ondansetron Hydrochloride | Bestochem Formulations India |
| Emeset | Ondansetron Hydrochloride | Cipla; CZ Pharma; Neopharm, Thailand |
| Emnil | Ondansetron Hydrochloride | Vilberry Healthcare |
| Entron | Ondansetron Hydrochloride | Ethica Industri Farmasi |
| Fixca | Ondansetron Hydrochloride | Grupo Vita / Vita Cientifica |
| Helmine | Ondansetron Hydrochloride | GlaxoSmithKline |
| Izofran | Ondansetron Hydrochloride | GlaxoSmithKline |